Advent of the cancer methylome

Combinatorial Chemistry and High Throughput Screening

Volumn 15, Issue 3, 2012, Pages 216-220

  Nai, Huey Shan ^a   Lau, Quek Choon ^a  

^a DEPARTMENT OF ELECTRONICS AND COMPUTER ENGINEERING   (Singapore)

Author keywords

Biomarker; Cancer; CpG islands; DNA methylation; Epigenome; Methylome; Tumor suppressor gene

Indexed keywords

ANTIBODY; BIOLOGICAL MARKER; BISULFITE; GENOMIC DNA; RESTRICTION ENDONUCLEASE;

CANCER DIAGNOSIS; CANCER GROWTH; CANCER THERAPY; CARCINOGENESIS; CPG ISLAND; DNA METHYLATION; DNA SEQUENCE; DRUG EFFICACY; GENE SEQUENCE; HPAII TINY FRAGMENT ENRICHMENT BY LIGATION MEDIATED POLYMERASE CHAIN REACTION; HUMAN; IMMUNOPRECIPITATION; INFINIUM ASSAY; METHYLOME; MICROARRAY ANALYSIS; NANOPORE; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; PROCEDURES; PROGNOSIS; RESTRICTION LANDMARK GENOMIC SCANNING; REVIEW; TUMOR GENE;

ANIMALS; CPG ISLANDS; DNA; DNA METHYLATION; GENES, NEOPLASM; GENETIC TECHNIQUES; HIGH-THROUGHPUT SCREENING ASSAYS; HUMANS; NEOPLASMS;

EID: 84858194785     PISSN: 13862073     EISSN: 18755402     Source Type: Journal    
DOI: 10.2174/138620712799218590     Document Type: Review

References (35)

1. Sharma, S.; Kelly, T. K.; Jones, P. A. Epigenetics in cancer. Carcinogenesis, 2010, 31 (1), 27-36.
2. Lau, Q. C.; Raja, E.; Salto-Tellez, M.; Liu, Q.; Ito, K.; Inoue, M.; Putti, T. C.; Loh, M.; Ko, T. K.; Huang, C.; Bhalla, K. N.; Zhu, T.; Ito, Y.; Sukumar, S. RUNX3 is frequently inactivated by dual mechanisms of protein mislocalization and promoter hypermethylation in breast cancer. Cancer Res., 2006, 66 (13), 6512-6520. (Pubitemid 44085605)
3. Tan, S. H.; Ida, H.; Lau, Q. C.; Goh, B. C.; Chieng, W. S.; Loh, M.; Ito, Y. Detection of promoter hypermethylation in serum samples of cancer patients by methylation-specific polymerase chain reaction for tumour suppressor genes including RUNX3. Oncol. Rep., 2007, 18 (5), 1225-1230.
4. Feinberg, A. P. Genome-scale approaches to the epigenetics of common human disease. Virchows Arch., 2010, 456 (1), 13-21.
5. Jungel, A.; Ospelt, C.; Gay, S. What can we learn from epigenetics in the year 2009? Curr. Opin. Rheumatol., 2010, 22 (3), 284-292.
6. Hatada, I.; Hayashizaki, Y.; Hirotsune, S.; Komatsubara, H.; Mukai, T. A genomic scanning method for higher organisms using restriction sites as landmarks. Proc. Natl. Acad. Sci. USA, 1991, 88 (21), 9523-9527. (Pubitemid 21915663)
7. Noushmehr, H.; Weisenberger, D. J.; Diefes, K.; Phillips, H. S.; Pujara, K.; Berman, B. P.; Pan, F.; Pelloski, C. E.; Sulman, E. P.; Bhat, K. P.; Verhaak, R. G.; Hoadley, K. A.; Hayes, D. N.; Perou, C. M.; Schmidt, H. K.; Ding, L.; Wilson, R. K.; Van Den Berg, D.; Shen, H.; Bengtsson, H.; Neuvial, P.; Cope, L. M.; Buckley, J.; Herman, J. G.; Baylin, S. B.; Laird, P. W.; Aldape, K. Identification of a CpG island methylator phenotype that defines a distinct subgroup of glioma. Cancer Cell, 2010, 17 (5), 510-522.
8. Costello, J. F.; Fruhwald, M. C.; Smiraglia, D. J.; Rush, L. J.; Robertson, G. P.; Gao, X.; Wright, F. A.; Feramisco, J. D.; Peltomaki, P.; Lang, J. C.; Schuller, D. E.; Yu, L.; Bloomfield, C. D.; Caligiuri, M. A.; Yates, A.; Nishikawa, R.; Su Huang, H.; Petrelli, N. J.; Zhang, X.; O'Dorisio, M. S.; Held, W. A.; Cavenee, W. K.; Plass, C. Aberrant CpG-island methylation has non-random and tumour-type-specific patterns. Nat. Genet., 2000, 24 (2), 132- 138.
9. Hanafusa, T.; Yumoto, Y.; Mimura, T.; Shinji, T.; Hada, H.; Koide, N.; Tsuji, T. Genome aberrations observed by restriction landmark genome scanning analysis of chromosomal DNA in various types of primary hepatocellular carcinoma. Hepatogastroenterology, 2002, 49 (44), 482-486. (Pubitemid 34614521)
10. Park, J.; Brena, R. M.; Gruidl, M.; Zhou, J.; Huang, T.; Plass, C.; Tockman, M. S. CpG island hypermethylation profiling of lung cancer using restriction landmark genomic scanning (RLGS) analysis. Cancer Biomark, 2005, 1 (2-3), 193-200.
11. Asaga, S.; Ueda, M.; Jinno, H.; Kikuchi, K.; Itano, O.; Ikeda, T.; Kitajima, M. Identification of a new breast cancer-related gene by restriction landmark genomic scanning. Anticancer Res., 2006, 26 (1A), 35-42. (Pubitemid 43206057)
12. Wang, S. S.; Smiraglia, D. J.; Wu, Y. Z.; Ghosh, S.; Rader, J. S.; Cho, K. R.; Bonfiglio, T. A.; Nayar, R.; Plass, C.; Sherman, M. E. Identification of novel methylation markers in cervical cancer using restriction landmark genomic scanning. Cancer Res., 2008, 68 (7), 2489-2497. (Pubitemid 351521825)
13. Frigola, J.; Ribas, M.; Risques, R. A.; Peinado, M. A. Methylome profiling of cancer cells by amplification of inter-methylated sites (AIMS). Nucleic Acids Res., 2002, 30 (7), e28.
14. Liang, G.; Gonzalgo, M. L.; Salem, C.; Jones, P. A. Identification of DNA methylation differences during tumorigenesis by methylation-sensitive arbitrarily primed polymerase chain reaction. Methods (San Diego, Calif), 2002, 27 (2), 150-155. (Pubitemid 34757127)
15. Khulan, B.; Thompson, R. F.; Ye, K.; Fazzari, M. J.; Suzuki, M.; Stasiek, E.; Figueroa, M. E.; Glass, J. L.; Chen, Q.; Montagna, C.; Hatchwell, E.; Selzer, R. R.; Richmond, T. A.; Green, R. D.; Melnick, A.; Greally, J. M. Comparative isoschizomer profiling of cytosine methylation: the HELP assay. Genome Res., 2006, 16 (8), 1046-1055. (Pubitemid 44162264)
16. Oda, M.; Greally, J. M. The HELP assay. Methods in Mol. Biol., 2009, 507, 77-87.
17. Toyota, M.; Ho, C.; Ahuja, N.; Jair, K. W.; Li, Q.; Ohe-Toyota, M.; Baylin, S. B.; Issa, J. P. Identification of differentially methylated sequences in colorectal cancer by methylated CpG island amplification. Cancer Res., 1999, 59 (10), 2307-2312.
18. Estecio, M. R.; Yan, P. S.; Ibrahim, A. E.; Tellez, C. S.; Shen, L.; Huang, T. H.; Issa, J. P. High-throughput methylation profiling by MCA coupled to CpG island microarray. Genome Res., 2007, 17 (10), 1529-1536.
19. Gao, W.; Kondo, Y.; Shen, L.; Shimizu, Y.; Sano, T.; Yamao, K.; Natsume, A.; Goto, Y.; Ito, M.; Murakami, H.; Osada, H.; Zhang, J.; Issa, J. P.; Sekido, Y. Variable DNA methylation patterns associated with progression of disease in hepatocellular carcinomas. Carcinogenesis, 2008, 29 (10), 1901-1910.
20. Kuang, S. Q.; Tong, W. G.; Yang, H.; Lin, W.; Lee, M. K.; Fang, Z. H.; Wei, Y.; Jelinek, J.; Issa, J. P.; Garcia-Manero, G. Genomewide identification of aberrantly methylated promoter associated CpG islands in acute lymphocytic leukemia. Leukemia, 2008, 22 (8), 1529-1538.
21. Nouzova, M.; Holtan, N.; Oshiro, M. M.; Isett, R. B.; Munoz- Rodriguez, J. L.; List, A. F.; Narro, M. L.; Miller, S. J.; Merchant, N. C.; Futscher, B. W. Epigenomic changes during leukemia cell differentiation: analysis of histone acetylation and cytosine methylation using CpG island microarrays. J. Pharm. Exp. Ther., 2004, 311 (3), 968-981.
22. Irizarry, R. A.; Ladd-Acosta, C.; Carvalho, B.; Wu, H.; Brandenburg, S. A.; Jeddeloh, J. A.; Wen, B.; Feinberg, A. P. Comprehensive high-throughput arrays for relative methylation (CHARM). Genome Res., 2008, 18 (5), 780-790. (Pubitemid 351645068)
23. Weber, M.; Davies, J. J.; Wittig, D.; Oakeley, E. J.; Haase, M.; Lam, W. L.; Schubeler, D., Chromosome-wide and promoter-specific analyses identify sites of differential DNA methylation in normal and transformed human cells. Nat. Genet., 2005, 37 (8), 853-862. (Pubitemid 41077111)
24. Keshet, I.; Schlesinger, Y.; Farkash, S.; Rand, E.; Hecht, M.; Segal, E.; Pikarski, E.; Young, R. A.; Niveleau, A.; Cedar, H.; Simon, I. Evidence for an instructive mechanism of de novo methylation in cancer cells. Nat. Genet., 2006, 38 (2), 149-53. (Pubitemid 43177227)
25. Jacinto, F. V.; Ballestar, E.; Ropero, S.; Esteller, M. Discovery of epigenetically silenced genes by methylated DNA immunoprecipitation in colon cancer cells. Cancer Res., 2007, 67 (24), 11481-11486.
26. Rauch, T.; Li, H.; Wu, X.; Pfeifer, G. P. MIRA-assisted microarray analysis, a new technology for the determination of DNA methylation patterns, identifies frequent methylation of homeodomain-containing genes in lung cancer cells. Cancer Res., 2006, 66 (16), 7939-7947. (Pubitemid 44299157)
27. Rauch, T. A.; Wu, X.; Zhong, X.; Riggs, A. D.; Pfeifer, G. P. A human B cell methylome at 100-base pair resolution. Proc. Natl. Acad. Sci. USA, 2009, 106 (3), 671-678.
28. Mohandas, T.; Sparkes, R. S.; Shapiro, L. J., Reactivation of an inactive human X chromosome: evidence for X inactivation by DNA methylation. Science 1981, 211 (4480), 393-396. (Pubitemid 11128749)
29. Jones, P. A.; Taylor, S. M.; Mohandas, T.; Shapiro, L. J. Cell cycle-specific reactivation of an inactive X-chromosome locus by 5-azadeoxycytidine. Proc. Natl. Acad. Sci. USA, 1982, 79 (4), 1215-1219. (Pubitemid 12105578)
30. Ibanez de Caceres, I.; Dulaimi, E.; Hoffman, A. M.; Al-Saleem, T.; Uzzo, R. G.; Cairns, P. Identification of novel target genes by an epigenetic reactivation screen of renal cancer. Cancer Res., 2006, 66 (10), 5021-5028. (Pubitemid 43844922)
31. Suzuki, H.; Gabrielson, E.; Chen, W.; Anbazhagan, R.; van Engeland, M.; Weijenberg, M. P.; Herman, J. G.; Baylin, S. B. A genomic screen for genes upregulated by demethylation and histone deacetylase inhibition in human colorectal cancer. Nat. Genet., 2002, 31 (2), 141-149.
32. Jeltsch, A.; Walter, J.; Reinhardt, R.; Platzer, M. German human methylome project started. Cancer Res., 2006, 66 (14), 7378. (Pubitemid 44197722)
33. Zhang, Y.; Rohde, C.; Tierling, S.; Jurkowski, T. P.; Bock, C.; Santacruz, D.; Ragozin, S.; Reinhardt, R.; Groth, M.; Walter, J.; Jeltsch, A. DNA methylation analysis of chromosome 21 gene promoters at single base pair and single allele resolution. PLoS Genet., 2009, 5 (3), e1000438.
34. Clarke, J.; Wu, H. C.; Jayasinghe, L.; Patel, A.; Reid, S.; Bayley, H. Continuous base identification for single-molecule nanopore DNA sequencing. Nat. Nanotechnol., 2009, 4 (4), 265-270.
35. Flusberg, B. A.; Webster, D. R.; Lee, J. H.; Travers, K. J.; Olivares, E. C.; Clark, T. A.; Korlach, J.; Turner, S. W. Direct detection of DNA methylation during single-molecule, real-time sequencing. Nat. Methods, 2010, 7 (6), 461-465.